A SCID-hu in vivo model of human Waldenström macroglobulinemia.
about
MicroRNAs in multiple myeloma and related bone diseaseIn vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myelomaNovel therapeutic strategies targeting growth factor signalling cascades in multiple myeloma.CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia.Navigating the bone marrow niche: translational insights and cancer-driven dysfunction.Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma.Molecular pathogenesis of Waldenstrom's macroglobulinemia.The bone marrow microenvironment in waldenstrom macroglobulinemia.Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma.Emerging pathways as individualized therapeutic target of multiple myeloma.Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse modelsMyeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities.miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies.A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.Mouse models of multiple myeloma: technologic platforms and perspectives.
P2860
Q26770478-AEA0A4F4-179F-4706-81F6-589EA9B94740Q35108549-1CCA9ADE-CC31-4A76-A354-0B384A6125FAQ36367811-0E1AB825-BE03-4C00-B6FA-CA5A9364DF43Q37001989-65894BAE-549B-4A2E-B556-B2CA847E9E2FQ37101382-1E611F76-6815-4EC3-B6AE-9B66033093F8Q38016511-04220A9A-1E93-44BD-AA65-2102177E64E4Q38024773-9FB54B0D-E7C0-4426-9B56-8BE1CF7052FDQ38095959-370F4740-2C89-42F5-B794-A24E79AED6D1Q38108387-2F2210E1-A7DC-4453-AD32-2F98A89C8411Q38112176-F3C88B01-F7A7-4FE6-8AFC-83B3A9DDC929Q38150849-2CE9C6E1-1E01-41E9-AC2C-27C9A71BF319Q38299932-259C3C2E-FF50-45A3-A276-5755DEC95CE5Q38476564-8072BE9F-1A1F-4613-A720-EDB93AAB8BF9Q51735874-5E8E0462-E309-47DC-810D-B657528235ABQ55038802-2FD6350D-E064-4A5E-8ED2-5856459D7A2D
P2860
A SCID-hu in vivo model of human Waldenström macroglobulinemia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A SCID-hu in vivo model of human Waldenström macroglobulinemia.
@en
A SCID-hu in vivo model of human Waldenström macroglobulinemia.
@nl
type
label
A SCID-hu in vivo model of human Waldenström macroglobulinemia.
@en
A SCID-hu in vivo model of human Waldenström macroglobulinemia.
@nl
prefLabel
A SCID-hu in vivo model of human Waldenström macroglobulinemia.
@en
A SCID-hu in vivo model of human Waldenström macroglobulinemia.
@nl
P2093
P2860
P1433
P1476
A SCID-hu in vivo model of human Waldenström macroglobulinemia.
@en
P2093
Daniel Ditzel Santos
Evdoxia Hatjiharissi
Jeffery L Kutok
Nikhil C Munshi
Olivier Tournilhac
Paola Neri
Pierfrancesco Tassone
Salvatore Venuta
Steven P Treon
Vidit Munshi
P2860
P304
P356
10.1182/BLOOD-2004-11-4477
P407
P577
2005-05-10T00:00:00Z